EN
FR
Export
export
Export
PDF
Excel (XLSX)
Word (DOCX)
You can select particular sections to be included in the output file.
Select all
Select classic EML layout
Indication
ICD-11
ATC codes
List type
Formulations
Therapeutic alternatives
Footnote
INN
Medicine type
Antibiotic groups
Sex
Age
Age restriction
Weight restriction
Patent information
Expert Committee decision justification
Cancel
Download
EN
FR
Model List of Essential Medicines
clear
Found 11 recommendations for 4 medicines and 0 therapeutic equivalents
Removed recommendations and rejected applications are shown.
Hide them
.
8.2.5. Supportive medicines
Allopurinol
General information
Section
Supportive medicines
Oral > Solid: 100 mg; 300 mg
Indications
Tumour lysis syndrome
Mesna
General information
Section
Supportive medicines
Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule
Oral > Solid: 400 mg; 600 mg
Indications
Osteosarcoma of bone and articular cartilage of other specified sites
Other specified malignant neoplasms of the ovary
Germ cell tumour of testis
Ewing sarcoma of bone and articular cartilage of unspecified sites
Rhabdomyosarcoma primary site
Unspecified malignant neoplasms of ill-defined or unspecified sites
Burkitt lymphoma including Burkitt leukaemia
Malignant neoplasms of kidney, except renal pelvis
Rasburicase
General information
Section
Supportive medicines
Parenteral > General injections > IV: 1.5 mg in vial powder and solvent for solution; 7.5 mg in vial powder and solvent for solution
Indications
Tumour lysis syndrome
Zoledronic acid
General information
Section
Supportive medicines
Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle
Indications
Malignant neoplasm metastasis in bone or bone marrow
Model List of Essential Medicines